At launch they will have more than 80 sites across 2 continents, spanning from Lima, Peru to Calgary, Canada – some 7,800 kilometers. Venn sites former FDA commissioner Scot Gottlieb’s recent call to arms for the clinical research industry to embrace desperately needed change to modernize and eliminate inefficiency in the conduct of clinical trials.īy combining their strengths and through further integration, the alliance will be sure to turn some heads. Further, by leveraging each members’ individual successes, efficiencies are exponential and will resonate across the industry as it seeks a better path forward”. “hyperCORE is fundamentally different” said Karri Venn, President, LMC Manna Research and hyperCORE founding Board member, “While others pursue models of loosely affiliated research sites, or activation of research naïve physicians and health clinics, hyperCORE builds upon the success of a tightly integrated and professional research site model already proven by its founding members. Its primary goal is to modernize the highly fragmented and inefficient research site model by assembling the industry’s leading site networks under one moniker facilitating exponential efficiencies at an unprecedented scale. Its unique ownership model combines the strengths of 8 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs. It forms the second largest site network in the world with more than 80 sites across 5 countries on 2 continents. Its unique ownership model combines the strengths of 8 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs.ĪpColumbus, GA (PRWEB) – Announcing the launch of hyperCORE International LLP, a Super Network of highly awarded and experienced Clinical Research Site Organizations. sites on the Pfizer and Moderna #COV19 vaccine trials.Announcing the launch of hyperCORE International LLP, a Super Network of highly awarded and experienced Clinical Research Site Organizations. Sponsors are taking notice and driving a lot of this shift.Īt the outset of COVID, CRIO’s system was leveraged by nearly a quarter of the U.S. Investors built these networks for three unique reasons (that aren’t going away).ġ) Centralized business development places studies at multiple sites with centralized contracting and budgeting.Ģ) Local recruiting x National Marketing makes it easier to fill studies.ģ) Standardized operations and systems mean a single electronic source template for sites with centralized and offshore #EDC entry and other activities. There are 5X as many site networks today as in 2015. Orantes, Co-Chief Diversity Officer of hyperCORE & CEO at Alcanza Clinical Research Nicholas Focil, Chief Quality Management Officer at hyperCORE & CEO FOMAT Medical Research Nathan Morton, Chief Vaccine Officer at hyperCORE & Chief Commercial Officer at Alcanza Clinical Research #researchaccelerated #clinicalresearch #networking #supernetwork ROBERTO Aguirre, Chief Medical Officer at hyperCORE & VP/Global Medical Director at AGA Clinical Trials Carlos E. Samir Arora, Chief Corporate Development Officer of hyperCORE & CGO at Centricity Researchĭr. Jeff Kingsley, COO of hyperCORE & CEO at Centricity Research Jeffrey Smyth, CFO of hyperCORE & Executive Director at TrueBlue Clinical Researchĭr. Mark Lacy, Chairman of hyperCORE & CEO of Benchmark Research Karri Venn, CEO of hyperCORE & COO at Centricity Researchĭr. Say hello to our hyperCORE leadership at World Vaccine Congress: Find out what strategic partnerships within our super network can do to accelerate your #clinicaltrials site capabilities in both quality and #diversity. Our leadership team is headed to The World Vaccine Congress 2023 on April 3-6 in Washington, DC, and we look forward to seeing you there! Make sure to schedule a meeting with Michael Casey, Executive Director of hyperCORE, or reach out to our leadership team when you stop by Booth 501.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |